Reducing damage to the nuclei of heart muscle cells improved heart function and extended survival in mice with a form of ...
Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes ...
A potentially life-changing heart condition, dilated cardiomyopathy, can be caused by the cumulative influence of hundreds or thousands of genes and not just by a single "aberrant" genetic variant, as ...
“Heart disease is not a death sentence. It has shaped my life but it hasn’t stopped me living it.” ...
Novel mavacamten had a big impact on quality of life in obstructive hypertrophic cardiomyopathy, according to a secondary analysis of the EXPLORER-HCM trial. The cardiac myosin inhibitor improved ...
Dilated cardiomyopathy (DCM) is a serious medical condition that affects approximately 1 in every 250 people. In DCM, the heart muscle dilates but cannot contract normally, making it difficult to ...
Apical hypertrophic cardiomyopathy is a rare condition where the heart walls thicken at the left ventricle’s apex, making it harder for the ventricle to pump. Symptoms are often vague or absent, but ...